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Background: Glutathione transferases (GSTs) constitute
a family of isoenzymes that catalyze the conjugation of the
tripeptide glutathione with a wide variety of hydrophobic
compounds bearing an electrophilic functional group.
Recently, a number of X-ray structures have been
reported which have defined both the glutathione- and
the substrate-binding sites in these enzymes. The structure
of the glutathione-free enzyme from a mammalian source
has not, however, been reported previously.
Results: We have solved structures of a human alpha-
class GST, isoenzyme Al-l, both in the unliganded form
and in complexes with the inhibitor ethacrynic acid and
its glutathione conjugate. These structures have been
refined to resolutions of 2.5 A, 2.7 A and 2.0 A respec-
tively. Both forms of the inhibitor are clearly present in
the associated electron density.
Conclusions: The major differences among the three
structures reported here involve the C-terminal ac-helix,
which is a characteristic of the alpha-class enzyme. This
helix forms a lid over the active site when the
hydrophobic substrate binding site (H-site) is occupied
but it is otherwise disordered. Ethacrynic acid appears to
bind in a non-productive mode in the absence of the
coenzyme glutathione.
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Introduction
Glutathione transferases (GSTs; EC 2.5.1.18) catalyze the
nucleophilic attack of the sulphur atom of glutathione on
the electrophilic groups of a wide range of hydrophobic
compounds of both endobiotic and xenobiotic origins.
Through this reaction they play an important role in
cellular detoxification and have been described as the
most important group of enzymes involved in the metab-
olism of electrophilic compounds [1]. The glutathione
adducts produced by the reaction generally have greater
water solubility than the free compounds, facilitating
their removal from the cell to be degraded to mercap-
turates before being excreted. Additionally, the elec-
trophilic compounds are often, though not in all cases,
rendered less toxic by the conjugation reaction. GSTs
have been the subject of many reviews (e.g. [1-5]). In
addition to their role in detoxification, GSTs may be
involved in the intracellular storage and transport of a
variety of other hydrophobic, non-substrate compounds
including hormones, metabolites and drugs. They have
also been the focus of considerable interest with regard to
drug resistance as certain drug-resistant tumour cells have
elevated levels of GSTs (see [6] for a review).
That there is such a diversity of substrates for GST is a
consequence not only of the fact that individual enzymes
can accommodate a wide variety of substrate molecules
[2] but also of the existence of many isoenzymes [7]. The
isoenzymes found in the mammalian cytosol have been
grouped into four species-independent classes (alpha, pi,
mu and theta) based on their substrate and inhibitor
specificities, antibody cross-reactivity and primary struc-
tures [8,9]. Many substrates, however, show activity with
GSTs of more than one class. The intracellular level of
each isoenzyme is markedly tissue-dependent [2]; the
sequence homology within a class is -75%, whereas
between classes it is in the order of 20-30%.
The fully functional enzymes are dimers of molecular
weight -50000 Da. The dimers can be formed either
from identical monomers or from different monomers
within the same class of isoenzyme [10]. No cross-class
heterodimers, however, have been discovered. Over the
past few years, structures have been reported of the
enzymes from the pi [11-13], mu [14-17] and alpha [18]
classes (see [4,5,18] for reviews and structural compar-
isons). Recently, two structures of GSTs from non-
mammalian sources have also been elucidated: a GST
from the Australian sheep blowfly, Lucilia cuprina [19],
and one from the parasitic worm, Schistosoma japonica
[20]. The overall structures of all these GST proteins are
similar [18]. Each subunit contains two domains: an
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N-terminal a/43-domain, with 3ot[oaPP3o topology, and
a C-terminal a-helical domain. Within the active site,
which is situated in spatially equivalent positions in all
three classes (pi, mu and alpha), there are two distinct
subsites: a glutathione-binding site (G-site) and a pocket
in which the hydrophobic substrates bind (H-site).
In each of the structures reported, glutathione makes a
network of specific interactions with polar groups from
both subunits of the GST dimer. Despite the fact that the
glutathione-binding pocket is only completed on dimer-
ization, there is no evidence of cooperativity between the
subunits [2,7]. Also, whereas the G-site is similar in all
structures [18], the H-site shows more variation. Both the
extension of a loop in domain 1 of the mu class enzymes
[14] and differences among the C terriini of the respec-
tive enzymes contribute to this diversity. The polypeptide
chains of the enzymes from the mu and pi classes are
some four to eight residues shorter than those from the
alpha class, which contain an additional C-terminal
oa-helix. This helix packs onto the hydrophobic substrate,
partially sealing it from the surrounding solvent [18].
Recently, Ji et al. [16] have examined the structures of a
mu-class GST bound to the diastereoisomers of 9-(S-
glutathionyl)- 10-hydroxy-9,10-dihydrophenanthrene and
Garcia-Siez et al. [13] have determined the structures of
S-(p-nitrobenzyl) glutathione and other inhibitors bound
to a GST from the pi class. These studies have con-
tributed to defining the H-site in these two classes. To
the same end, we have solved the structures of a human
alpha-class GST, Al-1, complexed with the inhibitor
ethacrynic acid (EA) ([2,3-dichloro-4-{2-methylene-1-
oxobutyl}phenoxy]acetic acid) and its glutathione conju-
gate (EA-GSH). GST Al-1 is the major isoenzyme
found in human liver, where it represents -2% of the
total cytosolic protein [7,21].
EA (Fig. la) is a potent diuretic drug which has been
shown to inhibit the alpha, pi and mu classes of GST
[22-24]. It is a phenoxyacetic acid compound with an
oa,3-unsaturated ketone moiety in the side chain. GSTs
catalyze the reaction of this unsaturated bond with
glutathione to form the glutathione conjugate. The reac-
tion is particularly efficient in the pi-class enzymes [2].
Although the catalytic efficiency is somewhat poor in the
alpha class, EA still acts as a good inhibitor, with 150 val-
ues of approximately 10 M. These values are even
lower for EA-GSH (0.8-2.8 IM) [24].
The inhibition of GST by EA has attracted particular
interest with regard to drug resistance in tumour cells. It
has been used to examine the role of GSTs in drug resis-
tance in vitro, using cell lines [22,23,25], and colon
tumour xenografts [26]. It has also been used with mod-
erate success in Phase I clinical trials, in which the effects
of administering EA to cancer patients along with the
alkylating agents thiotepa or melphalan were monitored
[27,28]. It is assumed that GSTs catalyze the conjugation
of such alkylating agents with glutathione, rendering
Fig. 1. Schematic representation of (a) EA and (b) EA-GSH. The
glutathione moiety is represented by SG.
them ineffective as anti-cancer drugs. By administering
EA along with these drugs, their rate of clearance from
the body is reduced.
We report here the structures of alpha-class GST Al-l
both in the apo-form and in complexes with EA and
EA-GSH. The apo-form is the first structure reported of
any mammalian GST with an unoccupied G-site, though
the structure of a glutathione-free GST from a parasitic
worm has recently been solved [20]. In the structure of
the complex with the conjugated form of glutathione,
Argl5 is replaced by a lysine residue. This mutation of a
residue in the active site has only a moderate effect on
the catalytic properties of the enzyme and produces
better-diffracting crystals [29]. Residues are numbered
according to Sinning et al. [18] with the N-terminal
alanine residue labelled Ala2.
Results and discussion
Human alpha-class glutathione Al-l has now been
crystallized both in the apo-form and in the presence of
three rather different inhibitors; EA, EA-GSH and
S-benzyl-GSH [18]. Thus we have structures of the
enzyme with neither glutathione nor substrate bound,
with only substrate bound (EA, in this case), and with
two different glutathione conjugates, (S-benzyl-GSH, a
relatively small inhibitor, and EA-GSH, which is bulkier
and charged). This latter complex has been refined
against data extending to a dmin of 2 A, significantly
higher than the resolution limit of the data that we have
obtained for the other crystals (see the Materials and
methods section and [18]). Interestingly, the crystallo-
graphic association of the dimers within this crystal is
slightly altered with respect to the other structures, pro-
ducing a new, but closely related, crystal form.
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Crystal packing arrangement
Under the conditions used for crystallization, crystals
usually grow with two dimers in the asymmetric unit that
are related by an operator involving a translation of 0.5 of
the unit cell along the c axis and a rotation of ~3 ° . Only
small adjustments are needed, therefore, for the non-crys-
tallographic symmetry operator to be converted into an
exact crystallographic relationship, resulting in a halving
of the c cell dimension. In the crystal of the complex with
EA-GSH this is indeed what happens. Presumably, it is
this optimal packing arrangement which is responsible for
the better diffraction properties of the crystal.
It is unclear, however, what is responsible for the
variation in crystal packing. It does not appear to be
caused either by the mutation of residue 15 from argi-
nine to lysine (Arg15-Lys) or by the presence of the
EA-GSH conjugate, as we have obtained crystals of both
the Argl5--Lys mutant in complex with benzyl-GSH
and the wild-type enzyme in complex with EA-GSH,
and these both contain two dimers in the unit cell. Fur-
thermore, crystals of the enzyme complexed with other
compounds have been seen to change from the small to
the large unit cell as data collection progressed. These
results suggest that the differences are caused by subtle
changes in, for example, temperature or pH, however,
the proximity of the H-site to crystallographically
related molecules means that the ligand may also influ-
ence the crystal form. None of the residues affected by
ligand binding are involved in any well defined crystal
contacts. An overlay of the crystal packing arrangement
in the benzyl-GSH complex onto that of the EA-GSH
complex can be seen in Figure 2. One dimer of the
former structure was superimposed onto the respective
dimer in the latter structure by least-squares minimiza-
tion of the positions of the corresponding Ctx atoms.
There are two main regions where relatively well
defined, polar residues are involved in crystallographic
interactions: residues on the loop between helices or5"
and o6 of the A molecule (helices named according to
[18] and molecules of the dimer according to the
EA-GSH complex, where one is labelled A and the
other B) interact with residues from helices ax2 and oa5"
of symmetry-related A and B molecules respectively;
and residues on the loop between helices cx4 and a5' of
the B molecule interact with residues on helix o3 of a
symmetry-related A molecule. In both of these regions
the contacts are slightly different between the two crystal
forms but whether the variations cause, or are a result
of, the different packing is unclear. A detailed compari-
son of the crystal contacts is complicated by the fact that
the benzyl-GSH complex was refined with strict
non-crystallographic symmetry constraints.
When compared with the previously reported structure
of the enzyme complexed with benzyl-GSH [18], the
higher resolution of the EA-GSH complex structure
contains few significant differences other than in a num-
ber of side-chain conformations and peptide orienta-
tions. The water structure is much better defined in the
Fig. 2. Superposition of the benzyl-GSH structure and its symme-
try-related molecules (grey) on the EA-GSH structure and its
symmetry-related molecules (colour ramped along the dimer
according to residue number, starting with blue at the N terminus
and finishing with red at the C terminus). The orientation matrix
was determined by least-squares superposition of the corre-
sponding Ca atoms of one dimer, shown in thick lines in the dia-
gram, and this was then applied to each of the tetramers in the
benzyl-GSH structure. The ligand is shown in ball-and-stick rep-
resentation. The view is along b with c vertical and a horizontal.
Glu115 resides on the loop between helices a4 and ca5' and
Asn80 is found just after' helix a3. These regions are involved in
crystallographic interactions that may affect into which cell the
protein crystallizes.
higher resolution complex. The overall root mean square
(rms) deviations among the structures are given in Tables
1 and 2. It is evident from Table 1 that the dimer inter-
face is not affected either by the type of inhibitor bound
or by the change in crystal packing. The major variations
among the molecules are localized to the C terminus.
This constitutes part of the hydrophobic binding pocket
(H-site) and will be dealt with below.
Ethacrynic acid binding
In the two structures with EA (free and conjugated)
bound in the H-site, the respective inhibitors can be easily
located in the electron density. The protein-ligand interac-
tions occurring in each complex will be described in turn.
EA-GSH complex
In the EA-GSH complex the glutathione moiety is well
ordered and the hydrogen-bonding interactions described
for the benzyl-GSH structure [18] are preserved. On the
other hand, there are two conformations of the EA moi-
ety, clearly shown (Fig. 3) by the density associated with
the higher scattering chlorine atoms. The conjugation of
glutathione with EA results in two possible diastereo-
isomers, neither of which, at least in the rat enzyme
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GST 33, is preferentially selected [24]. As both of th
diastereoisomers should be present in the crystallization
mixture, it is possible that the two conformations of the
EA moiety represent different enantiomeric forms of the
conjugate. As the quality of the electron density at the
site of the conjugation is ambiguous, however, the two
conformations of the EA moiety have been modelled
such that only one enantiomer is represented in the final
structure. The major difference between the two confor-
mations is a rotation of the dichlorophenoxy group by
approximately 1400 around an axis which passes through
both 02 and C7 (see Fig. 1 for atomic naming conven-
tion) as well as through the centre of the ring. The acidic
side chains and carbonyl groups of each molecule are
almost superimposed (see Fig. 4).
The interactions with GST made by the EA moiety are
mainly hydrophobic in nature, with the dichlorophe-
noxy group in van der Waals contact with the Cot of
Gly14 and the side chains of residues PhelO, Leul07,
Leul08, Vallll, Met208 and Phe222. Despite the
hydrophobic nature of the H-site, both the carbonyl
oxygen 01 (Fig. 1) and the carboxylate oxygens are
involved in hydrogen-bonding interactions (Fig. 4). The
carbonyl oxygen acts as a hydrogen-bond acceptor from
the hydroxyl group of Tyr9 (O to OH distances range
from 2.8 A-3.3 A among the two conformations of the
Fig. 3. 2Fo-F density associated with the ligand in the EA-GSH
complex. The map was calculated using phases derived from a
model in the early stages of refinement, before the inclusion of
the ligand, and subjected to 10 cycles of averaging (contoured at
1 r). The two conformations of the inhibitor's EA moiety can be
distinguished by the colour of their carbon atoms (magenta for
one and brown for the other). The two conformations are shown
modelled as different enantiomeric forms of the inhibitor. In the
final structure, however, both conformations are modelled in the
same enantiomeric form as the density at the site of the conjuga-
tion cannot be unambiguously interpreted (see text).
EA moiety and the two molecules of the asymmetric
unit). In the wild-type enzyme it would also be within
potential hydrogen-bonding distance of Argl5 (NE
-3.3 A) assuming that the arginine residue retains the
same conformation as in the benzyl-GSH complex.
The carboxylate oxygens are involved in three potential
hydrogen-bonding interactions, one with the amino
nitrogen of Gly14 (3.0-3.2 A) and two with water mol-
ecules (Fig. 4). One of these water molecules is
conserved among all the solved GST Al-1 structures. It
lies 2.8-3.4 A from the carboxylate, has a relatively low
B-value (21 A2 and 36 A2 ill the A and B molecules,
respectively) and makes hydrogen bonds to both the
carbonyl oxygen of Pro207 (-2.9 A) and the amino
nitrogen of Argl3 (-2.7 A). The other is less well
defined (B-values of 45 A2 and 46 A2 in the A and B
molecules, respectively) and on average lies further from
the inhibitor (3.0-3.5 A). These interactions show that
the enzyme is able to interact with the polar atoms of
the substrate, despite the hydrophobic nature of the
binding site, by direct protein hydrogen bonds and
hydration effects.
Ethacrynic acid complex
The electron density for EA in the substrate-enzyme
complex is shown in Figure 5. In this structure, the
dichlorophenoxy ring appears to adopt only one
Table 1. Rms differences (in A) between selected atoms of the
high-resolution structure of the EA-GSH complex and the
other three structures.
Molecule A Molecule B Benzyl-GSH EA Apo-
of EA-GSH of EA-GSH complex complex enzyme
complex complex
Monomer
All Ca atoms 0.13 0.61 0.52 0.35
Ca atoms
(residues 5-207*) 0.12 0.26 0.23 0.30
All atoms 0.62 0.97 0.95 0.79
All atoms
(residues 5-207) 0.47 0.69 0.68 0.75
Dimer
Ca atoms 0.55 0.47 0.36
Ca atoms
(residues 5-207) 0.28 0.21 0.32
*This excludes the three N-terminal residues, which are not
well defined, and the C-terminal helix.
Table 2. Rms differences (in A) among the respective
monomers of the four structures.
Structure (residues 5-207 Benzyl-GSH EA Apo-
of the A molecule) complex complex enzyme
EA-GSH main chain 0.38 0.24 0.31
all atoms 0.69 0.68 0.75
Benzyl-GSH main chain - 0.36 0.34
all atoms - 0.69 0.72
EA main chain - - 0.23
all atoms - - 0.68
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Fig. 4. View of the H-site in the EA-GSH complex. The ribbon
representation of the molecule has been colour ramped accord-
ing to residue number as in Figure 2. The inhibitor's EA moiety is
shown in two conformations which can be differentiated by the
colour of their respective carbon atoms. In one conformation the
carbon atoms have been coloured brown and in the other
magenta. The carbon atoms of the protein are coloured yellow.
Possible hydrogen bonds are represented by cyan lines.
conformation. Both the shape of the density and the size
similarity of the substitutions to the phenol ring make
the assignment of the orientation ambiguous (see the
Materials and methods section). In our preferred model,
the carboxylate group is oriented towards, and partly
occupies, the G-site. Indeed, one of the carboxylate oxy-
gens lies 0.8 A from the sulphur position in the EA-GSH
complex. This oxygen atom is within hydrogen-bonding
distance of the hydroxyl group of Tyr9 (2.8 A). The
other oxygen is able to make two hydrogen bonds, one
directly to the protein to the carbonyl oxygen of Val55
(2.6 A), and the other indirectly to the amino nitrogen of
Val55 via a water molecule (B-value 38 A2). This bridg-
ing water molecule lies 2.8 A and 3.0 A away from the
carboxylate and the amino nitrogen, respectively (Fig. 6).
Although, at the pH of crystallization we would expect
the carboxylate group of EA to be charged, the inter-
action with the carbonyl of Val55 suggests that the group
has an elevated PKa and is protonated.
A comparison of the EA and EA-GSH complexes
shows that the EA is rotated by -180 ° around the bond
joining C3 to C4 in the phenyl ring (Fig. 7). This
moves the whole molecule towards the G-site, along
the plane of the dichlorophenoxy group, and causes the
reactive u,3-ketone group to point away from this site.
The position of the unconjugated EA, regardless of its
orientation, means that the substrate is bound in a non-
productive complex. It has to move in order for the
glutathione to bind. Differences in the conformation of
Fig. 5. 2Fo-F c electron density associated with the ligand in the EA
complex. The map was calculated using phases derived from a
model in the early stages of refinement, before the inclusion of the
ligand, and subjected to 10 cycles of averaging (contoured at 1 ).
The coordinates of the final structure have been superimposed.
The carbon atoms of the inhibitor are coloured brown to differen-
tiate them from those of the protein, which are coloured yellow.
the various species along the reaction coordinate of the
catalysis mediated by GST have been seen before [15].
The conformation of the tricyclohexadienate group in
the transition-state analogue, 1-(S-glutathionyl)-2,4,6-
trinitrocyclohexadienate bound to a mu-class enzyme,
is significantly different to the conformation of the cor-
responding dinitrobenzene in the product complex, 1-
(S-glutathionyl)-2,4-dinitrobenzene, when bound to
the same enzyme. On the basis of this comparison, Ji et
al. [15] proposed reaction coordinate motion during
catalysis. The. non-productive binding mode of EA that
we observe, however, is probably of little consequence
in vivo as the intracellular concentrations of glutathione
(1-10 mM) are much higher than its dissociation con-
stant (10-200 laM) and so the majority of the GST
should exist in a binary complex with glutathione.
Recently, the structure of the GST from the parasitic
worm Schistosoma japonica bound to another clinically
useful drug, the anti-schistosomal drug praziquantel, has
been reported [20]. The nature of inhibition of GST by
praziquantel contrasts markedly with that by EA. Prazi-
quantel does not bind to the active site but rather to the
'non-substrate-binding site' in the dimer interface where
larger, non-substrate molecules such as haem are thought
to bind. The drug is thought to interfere with the trans-
port functions of the GST in addition to sterically
hindering the binding of larger substrates to the H-site.
These two different drug complexes represent contrasting
ways of inhibiting GST.
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Fig. 6. View of the H-site of the EA complex. The ribbon repre-
sentation of the protein has been colour ramped according to
residue number as in Figure 2. The carbon atoms of the inhibitor
are coloured brown to distinguish them from those of the protein,
which are coloured yellow. Possible hydrogen-bonding inter-
actions involving the inhibitor are represented by cyan lines.
Apo-enzyme
In this study we hoped to address the important ques-
tions of, firstly, what conformational changes occur
when glutathione binds to alpha-class GSTs and,
secondly, how the enzyme is able to accommodate the
different types of ligand. It has been postulated that
when glutathione binds to the enzyme it does so by an
induced-fit mechanism [7]. We observe no significant
changes between the apo-enzyme and the product com-
plexes for residues 2-207. Between residues 5 and 207 of
the monomer, the rms deviation for main-chain atoms is
-0.3 A and for all atoms is -0.7 A (Table 2). As the
interaction between the enzyme and the glutathione
appears to be highly specific, as judged from a compari-
son of the product complexes, we can infer from the
above result that glutathione itself causes no significant
conformational change at the G-site on binding. What is
striking about the apo-structure, however, is the almost
total absence of any electron density associated with the
C-terminal a-helix. This helix, one edge of which is
made up of hydrophobic residues, forms a lid over the
H-site, providing a highly hydrophobic environment for
the substrate [18], and has been shown to be important,
though not essential, in catalysis [30]. In the structures of
the complexes with benzyl-GSH, EA and EA-GSH, the
helix can be observed in the electron density, although
in the last two structures a number of residues are not
well defined. It would appear, therefore, that the pres-
ence of a hydrophobic substrate, or possibly just
glutathione, stabilizes the helix. The closure of a lid over
the active site, in response to substrate binding, has been
Fig. 7. Superposition of the EA complex structure on that of the
EA-GSH complex showing the difference in the position of the
EA moiety. Both orientations of the EA moiety in the EA-GSH
complex are shown, with carbon atoms coloured magenta. The
carbon atoms belonging to EA in the EA complex have been
coloured brown. Protein carbon atoms are coloured yellow for
the EA-GSH complex and brown for the EA complex. The ribbon
representation of the Ca traces are coloured as in Figure 2 for the
EA-GSH complex and blue for the EA complex.-The-two mol-
ecules have been superimposed using a least-squares fit of the
Ca atoms of the respective monomers.
seen in a number of cases such as lactate dehydrogenase
[31] and triosephosphate isomerase [32]. In these cases
both open and closed conformations of the respective
loops have been observed. We see no 'open' conforma-
tion and no evidence to suggest that one should occur,
but rather the helix is disordered, with traces of electron
density at low contour levels occurring in the usual
position of the helix. None of the complexes show any
specific interactions between the residues on the helix
and the respective inhibitors. In the benzyl-GSH com-
plex, the structure in which the helix is most clearly
defined, only two helix residues, Phe220 and Phe222,
are within van der Waals distance of the inhibitor.
Phe220 is one of the best ordered side chains from the
helix in the three structures where it is evident. The side
chain is positioned to pack on top of the C3 atom of the
cysteinyl side chain of glutathione in a pocket made up
of other aromatic residues, Tyr9 and PhelO (Fig. 4). In
the apo-structure, the conformation of PhelO is such
that it would sterically hinder Phe220 from adopting the
position seen in the other three structures. There is no
apparent reason, however, why Phe10, which is not well
defined in any of the complex structures, should prefer-
entially adopt this orientation. It is probably a result of
the disorder of the helix rather than a cause. Regardless,
it seems that the environment around Phe220 (which
includes Tyr9, a residue of some importance to the
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catalytic mechanism) is critical in determining whether
the helix is ordered or not.
Comparison of the structures
It is mainly residues at the C terminus that are affected by
the binding of the different ligands. In order to accom-
modate the bulkier EA-GSH conjugate, Met208, which
is situated just before the C-terminal helix, has to move
out of the H-site. The movement of this residue, from
the position seen in all of the other structures, causes
some displacement of residues further down the helix
which also contribute to the formation of the H-site
(Fig. 8). The conformation of the helix in the EA com-
plex is more similar to that observed in the benzyl-GSH
complex than to that in the EA-GSH complex. In nei-
ther the EA-GSH nor the EA complexes is the helix as
well defined as in the benzyl-GSH complex. The average
real-space correlation coefficients for the main-chain
atoms of residues 208-222 are 0.85, 0.71 and 0.68 (0.85,
0.86 and 0.87 for residues 2-222), for the benzyl-GSH,
EA and EA-GSH complexes, respectively. These num-
bers suggest that with benzyl-GSH present in the H-site,
the helix is able to adopt its most 'stable' position. When
EA binds to the enzyme, instead of perturbing this stable
conformation unduly, it binds in a non-productive mode,
partially occupying the free G-site.
Fig. 8. Overlay of the EA-GSH and benzyl-GSH complexes
showing the displacement of the C-terminal a-helix of one rela-
tive to the other. The two molecules have been superimposed
based on a least-squares fit of the Ca atoms of the respective
monomers. The ribbon representation of the EA-GSH complex
has been colour ramped according to residue number as in Fig-
ure 2 and that of the benzyl-GSH complex is coloured light blue.
Both orientations of the EA moiety of EA-GSH are shown with
carbon atoms coloured magenta. The protein carbon atoms in
the EA-GSH complex are coloured yellow and all carbon atoms
in the benzyl-GSH complex brown.
Implications to activity
It is now reasonably well established that Tyr9, conserved
throughout the alpha-, mu- and pi-class GSTs, is important
in stabilizing the thiolate form of the glutathione (review-
ed in [4]). There has, however, been some debate as to
whether this residue could also act as a base and abstract
the proton from the glutathione. Garcia-Siez et al. [13]
have suggested that, should this tyrosine hydroxyl group
exist in the form Tyr-O-, some rearrangement of the
active site could occur in the absence of glutathione such
that a positively charged residue is brought into the
environment of the negatively charged ion. We see no
such arrangement in the apo-structure. Tyr9 retains the
same conformation in all the structures that we have
studied (e.g. Fig. 7). The only atom within hydrogen-
bonding distance of the tyrosine hydroxyl group in the
apo-structure is a water molecule with a relatively high
B-value (45 A2). In the two EA-containing structures,
the hydroxyl group is involved in hydrogen-bonding
interactions with the substrate, where it must act as the
hydrogen-bond donor. This suggests that Tyr9 is proto-
nated. These results are consistent with previous crystal-
lographic evidence where a close contact between the
negatively charged sulphonate group of glutathione
sulphonate and the equivalent tyrosine in the pi-class
enzyme was revealed, suggesting that the hydroxyl group
could not be charged [11].
The specific activity of GST Al-1 with EA is very low
[2,24]. Such conjugation reactions involving xa,[-unsatu-
rated carbonyl compounds normally involve nucleophilic
attack on the 13-alkene carbon, C11. The reactivity of
the nucleophile may be increased by a nearby base and
the electrophilicity of the 3-alkene carbon could also be
increased by protonation of the carbonyl oxygen [2]. In
GST Al-1, the only two polar residues that could possi-
bly be involved in this mechanism are Tyr9 and Argl5. In
the EA-GSH complex, the carbonyl oxygen 01 of the
EA is within hydrogen-bonding distance of both of these
residues (i.e. the hydroxyl of Tyr9 and the expected posi-
tion for the NE atom of Argl5 in the wild-type struc-
ture). As described above, the available evidence suggests
that these two residues are responsible for maintaining
the glutathione in the thiolate form [18,29] but they may
also have an effect on the electrophilicity of the carbonyl
oxygen. The mechanism could be explored more thor-
oughly using transition-state analogues, as in the mu-class
enzyme [15]. In both the mu- and pi-class enzymes,
which are more active for this class of substrate, another
conserved tyrosine may be involved in this mechanism
[16,33]. In the alpha-class enzymes this tyrosine is equiv-
alent to Vall 11 (Figs 6,7).
Biological implications
Glutathione transferases (GSTs) help to protect the
cell from potentially toxic alkylating agents that
carry electrophilic functional groups, by catalyzing
their conjugation with the tripeptide glutathione.
The existence of multiple isoforms of GST,
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together with the relatively non-specific binding of
the substrate, mean that a wide variety of com-
pounds, including certain anti-cancer drugs, can
be conjugated to glutathione. Despite the consid-
erable wealth of information in the literature about
GSTs a number of questions remain unanswered
concerning both the catalytic mechanism and sub-
strate recognition. We have solved the structures of
the alpha-class enzyme Al-1 in the apo-form and
in complexes with both ethacrynic acid (EA) and
the conjugate formed between EA and glutathione
(EA-GSH). EA has been administered to cancer
patients in attempts to increase the efficacy of
alkylating cytostatic drugs. The rationale is that
EA or EA-GSH would serve as GST inhibitors and
overcome the resistance caused by GST-dependent
inactivation of the cytostatic drug.
The apo-structure reported here is the first
mammalian GST structure to be solved in the
absence of a glutathione derivative. Comparison
of the various structures reveals that no significant
conformational changes occur in the glutathione
binding site (G-site) of the enzyme upon binding
of a glutathione derivative. On the other hand, the
absence of either substrate or inhibitor from the
binding site for the hydrophobic substrate (H-site)
causes the C-terminal o-helix, which is unique to
the alpha-class enzymes, to become disordered.
The helix forms a lid over the H-site upon bind-
ing of substrate or product.
In the structure of the complex with EA, the
substrate is revealed as binding in a non-produc-
tive mode, suggesting that the substrate will only
form an active complex when glutathione is
already bound. This is biologically sensible as the
intracellular levels of glutathione are much higher
than the dissociation constant of its complex with
GST Al-1. Glutathione is, therefore, probably
involved in the molecular recognition of the elec-
trophilic substrate and should be considered when
designing drugs to inhibit GST.
Materials and methods
Site-directed mutagenesis of GST Al-1 to generate the
Argl5--Lys mutant was carried out essentially as in [34].
Recombinant protein was expressed and purified as described
previously [35], with the exception that the protein was eluted
from the affinity column with 50 mM glycine-NaOH,
pH 10.0 rather than with S-hexyl-glutathione. Crystals of the
apo-protein were grown using procedures similar to those of
Cowan et al. [36]. Crystals of the enzyme in complexes with
EA and EA-GSH were grown by vapour diffusion using PEG
2000 monomethyl ether as the precipitant. 3 ,1l of a 55 mg
ml- ' protein solution was mixed with an equal volume of
reservoir liquor containing 10-20% PEG solution, 100 mM
Tris-HCI (pH 8.5), 30 mM NaAc (pH 4.6) and 1% -mercap-
toethanol. The ligand was added to the protein solution to give
a final concentration of 2.5 mM. EA-GSH was obtained from
a reaction between EA and reduced glutathione with no
attempt to select for either of the two possible enantiomers.
Crystals grew in one to two days at 200C. Data were recorded
at room temperature from the apo-crystals on a MAR imaging
plate on the EMBL beamline X31 at DESY, Hamburg and
processed using DENZO [37]. Data from the EA and
EA-GSH complexes were collected on a Rigaku R-AXIS
imaging plate mounted on a rotating anode source. The former
were collected at room temperature and processed using soft-
ware supplied by Rigaku [38] and the latter at 4C and
processed using DENZO [37] . A summary of the data collec-
tion methods and statistics is given in Table 3.
Refinement of the EA-GSH complex
Refinement of the EA-GSH complex was started using a
model derived from the benzyl-GSH complex [18], which had
undergone some preliminary refinement against the apo-
enzyme data. The halving of the c cell dimension of the crystal
of this complex with respect to that of the others (Table 3) was
assumed to be caused by a slight rearrangement of the mol-
ecules in the unit cell, such that the pseudo-crystallographic
symmetry described by Sinning et al. [18] had become crystal-
lographic and the asymmetric unit contained one rather than
two dimers. The initial model, therefore, contained one dimer
without the associated water molecules. The radius of conver-
gence of rigid-body refinement in X-PLOR [39], using data
between 10 A and 4 A, was sufficient to correctly orient the
two molecules of the dimer. To obtain the optimal non-
crystallographic symmetry operators the model was subjected
to a simulated annealing slow-cool protocol [40], treating both
molecules independently. The refinement was then restarted
using non-crystallographic symmetry constraints and thereafter
a 2Fo-F c map was calculated and subjected to -10 cycles of
averaging using RAVE [41]. The position of the inhibitor
could be clearly seen in this map. Manual rebuilding, in which
one monomer was fitted into the averaged electron density,
was carried out in O [42,43]. At this stage, only the glutathione
moiety of the ligand was inserted. Water molecules were
included at stereochemically sensible positions where peaks
were observed in the associated electron-density maps. Further
refinement was carried out using alternating steps of least-
squares refinement in X-PLOR (applying strict non-crystallo-
graphic symmetry constraints) and rebuilding into averaged
maps. Individual atomic temperature factors were refined with
tight restraints applied between bonded atoms. The free R-fac-
tor (Rfree [44]), based on 10% of the data, was used throughout
to guide the refinement procedure. During the later refinement
cycles the strict non-crystallographic symmetry constraints
were replaced by restraints and the two molecules of the dimer
were built into unaveraged 2Fo-F c maps.
The final structure of the complex between GST Al-1 and
EA-GSH has an R of 19.7% (all data, 7.5-2.0 A) and
cryst
excellent stereochemistry (Table 4). Of the non-glycine
residues, 92.6% have and J values which correspond to the
most favoured regions of a Ramachandran plot [45] and no
non-glycine residues lie in the disallowed regions, as defined
by Morris et al. [46]. The four residues in the benzyl-GSH
structure [18] which have pep-flip values [43] larger than 2.5
A again have high values. Compared with the benzyl-GSH
structure three peptides have been flipped: Val66, Va1149 and
Pro200. The final model includes all protein residues of the
dimer (except for the N-terminal two residues of the B mol-
ecule, for which no density could be observed), two mol-
ecules of EA-GSH, four molecules of 3-mercaptoethanol and
344 water molecules. The EA moiety of the inhibitor was
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Table 3. Data processing statistics.
EA-GSH complex Apo-enzyme EA complex
Space group
Wavelength (A)
No. of crystals
Data processing programs
Scaling program
Cell dimensions (a,b,c) (A)
dmin (A)
No. of observations
No. of unique reflections
Completeness (%)
Rmerget (%)
Reflections 1>3u (%)
Reflections 1>3a (%)
in highest resolution shell (%)
Bin resolution (A)
C2
1.54
1
DENZO [37]
CCP4
100.4, 94.8,
51.8, P=92.96°
2.0
64 609
30538
93.4
7.3
88
67
2.07-2.00
C2
0.92
1
DENZO
SCALEPACK
100.2, 94.8
104.0, 3=92.46 °
2.5
72511
31 802
97.5
10.7
81
61
2.54-2.50
C2
1.54
2
RAXIS [38]
RAXIS/ CCP4*
101.1, 95.6
105.3, =92.16
2.7
41 606
26 072
94.7
7.8
80
51
2.84-2.70
*Data from individual crystals were merged using the R-axis software [38] and the two data sets subsequently scaled together using
the CCP4 suite of programs [471. t Rmerge=lIobs-<l>I <I>.
modelled in two conformations with relative occupancies of
0.6 and 0.4. Figure 3 shows the coordinates of the final model
superimposed on an averaged 2F -F c electron-density map
calculated before the inclusion of the EA moiety in the
model. The average atomic B-value of the model is 27.1 A2
(28.5 A2 for EA-GSH). There are two regions where the
B-values are particularly high and the density of the maps cor-
respondingly poor: the C-terminal or-helix of both monomers
and, in the A molecule, the region comprising the loop
between helices 4 and oa5' and the N-terminal portion of
helix or5'. The latter is better defined in the B molecule,
where it is involved in crystallographic interactions. The vari-
ation of the B-values with residue number is very similar to
that of the benzyl-GSH complex [18].
A number of residues in the final model have been modelled in
two conformations. One of these, Arg89, lies at the dimer
interface close to a non-crytallographic symmetry related copy
of itself. In the low-resolution, averaged structure of the
enzyme complexed with benzyl-GSH the side chain was
modelled in just one conformation such that the generation of
the dimer by applying the non-crystallographic symmetry
operations resulted in a close contact between the two side
chains [18]. In the higher-resolution structure, it appears that
the guanidino group of both residues partially occupies the
same site. The two conformations modelled do not completely
satisfy the electron density. Another residue modelled in two
conformations is Glu104, which in the wild-type enzyme
forms a salt bridge with Argl5. In the Arg1l5--Lys mutant the
replacement of the arginine with a lysine disrupts the salt
bridge and causes Glu104 to be less well defined.
In each monomer there is a strange, crescent-shaped electron
density situated in a pocket lined by residues of both
hydrophobic and hydrophilic nature. This pocket resides near
the bottom of the crevice which is formed at the dimer inter-
face. Although the density cannot be fully accounted for by
any of the molecules within the crystallization mixture, its cres-
cent shape is suggestive of a disulphide and, as a consequence, a
2-hydroxyethyl disulphide has been inserted. In each protein
monomer one molecule of the disulphide has been modelled in
two conformations. The positions of the sulphur atoms lie
directly above the plane of the imidazole ring of Hisl59.
Refinement of the apo-structure and EA complex
The starting model for the refinement of both the apo-struc-
ture and the EA complex was derived from that of the
EA-GSH complex before the relaxing of the non-crystallo-
graphic symmetry constraints. The model included the full
dimer with the exception of the C-terminal residues beyond
Met208. EA-GSH and the P-mercaptoethanol-derived disul-
phide were omitted but the water molecules were included.
For the apo-form, the full tetramer of the asymmetric unit was
generated by placing the dimers at each of the two positions
defined in a model of this structure that had undergone some
preliminary refinement. For the EA complex, the tetramer was
generated by duplicating the dimer at a position displaced half a
unit-cell length in the direction of the c axis. The positions of
all molecules were optimized using rigid-body refinement.
Table 4. Refinement statistics of final models.
EA-GSH Apo- EA
complex enzyme complex
Resolution of data (A) 7.5-2.0 7.5-2.5 7.5-2.7
Rcryst* (%) 19.7 23.8 22.9
Rfree (%) 24.4 26.4 26.1
No. of atoms 4088t 1 793 1901 t
No. of water molecules 344 104 75
Deviations from ideality§
Bond lengths (A) 0.009 0.010 0.010
Bond angles (0) 1.44 1.43 1.46
Dihedrals (°) 21.5 21.4 21.5
Impropers (0) 1.41 1.30 1.31
Rms B-values between
bonded atoms (A2) 2.3 3.0 -
Rcryst=XhkIl IF b I -lFC FaCI / hkl I F°bI. tDimer refined
with non-crystallographic symmetry restraints. Monomer
refined with NCS constraints to form two dimers. §Ideal
parameters are those defined by Engh and Huber [48].
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Fig. 9. Electron-density maps associated
with EA after the inhibitor has been
refined in each of two conformations, as
described in the text. (a) The carboxy-
late pointing towards the G-site. (b) The
xa,3-ketone moiety pointing towards the
G-site. The corresponding coordinates
of the models have been superimposed.
The 2Fo-F c maps (blue) were subjected
to 10 cycles of averaging (contoured at
l1r). The F-F c maps were averaged
over the four molecules of the asymmet-
ric unit. Positive peaks are coloured
green and negative peaks are red.
Refinement of both structures was carried out in a manner
similar to that described above. Strict non-crystallographic
symmetry constraints were maintained throughout the refine-
ment. The averaged 2Fo-F c maps associated with the EA com-
plex, after the initial simulated annealing slow-cool procedure,
clearly revealed the position of the EA. As a result of the size
similarity of the substitutions in the phenol ring, however, the
quality of the density was not sufficient to define the orienta-
tion of the molecule unambiguously (i.e. either the ot,-ketone
or the acetic acid moieties could point towards the G-site).
Each of the possible orientations was tested by inserting EA
into the model, subjecting the structure to least-squares refine-
ment in X-PLOR, and then examining the resulting maps. In
Figure 9 the coordinates of the models resulting from these
tests are superimposed on the relevant maps. In each of the
Fo-F c maps there is a positive peak near the ligand and within
hydrogen-bonding distance of Val55. With the ligand in one
conformation the peak is within hydrogen-bonding distance of
the carboxylic acid group (Fig. 9a), and in the other it is very
close to the non-polar oa,3-ketone group (Fig. 9b). At the
opposite end of the EA molecule, neither the tx,3-ketone
group of the former model, nor the carboxylate of the latter,
completely satisfies the observed density. The surrounding
residues are, however, all hydrophobic and it is more likely that
the ot,-ketone group occupies this position than the polar car-
boxylate. Overall, therefore, we prefer the model in which the
carboxylate points towards the G-site, but the limited diffrac-
tion data do not rule out the other model, or a superposition of
both. For the apo-structure, individual atomic temperature
factors were refined with tight restraints applied between
bonded atoms, but, for the slightly lower-resolution EA struc-
ture only two temperature factors per residue were refined,
corresponding to the main-chain and side-chain atoms, respec-
tively. Refinement was terminated when no appreciable reduc-
tion in the Rfree could be obtained with further rebuilding.
The final models of the EA complex and apo-structure have
Rcryst values of 22.9% (7.5-2.7 A) and 23.7% (7.5-2.5 A),
respectively. The four molecules of the asymmetric unit of each
structure are identical because of the application of non-crystal-
lographic symmetry constraints during refinement. Details of
the stereochemical parameters etc. of these structures are shown
in Table 4. Whereas all protein atoms have been included in
the model of the EA complex, the C-terminal helix has been
omitted from the apo-structure due to the absence of any
associated electron density. The variation in main-chain tem-
perature factors and the real-space fit of each residue to its asso-
ciated electron density show a similar pattern to that shown by
the EA-GSH complex. The average B-value for the apo-struc-
ture is 26 A2 and that for the EA complex is 43 A2 (74 A2 for
EA alone). The inclusion of the C-terminal residues in the EA
complex structure contributes to the higher B-value compared
with that for the apo-structure. The site into which the disul-
phide was modelled in the EA-GSH complex again contains a
crescent-shaped feature in the relevant electron-density maps.
Because of the relatively low resolution of the data, however,
waters were inserted rather than the molecule containing a
disulphide bridge. In each structure, Arg89 appeared to make
similar interactions to those described for the EA-GSH com-
plex and was therefore modelled in two conformations.
Coordinates and structure factor amplitudes for the apo-
enzyme, the EA complex and the EA-GSH complex have
been deposited in the Brookhaven Protein Data Bank with
entry codes lGSD, 1GSE and 1GSF.
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